{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:31:50Z","timestamp":1792420310878,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The need to develop new and effective antimicrobial compounds has become a fundamental requirement of the therapeutic system worldwide. In this study, a series of synthetic 4-amino triazoloquinoxaline derivatives were designed and synthesized. The chemical structure of these compounds was confirmed using spectroscopic methods (\n                    <jats:sup>1<\/jats:sup>\n                    H-NMR,\n                    <jats:sup>13<\/jats:sup>\n                    C-NMR, FT-IR, and MS). Their antimicrobial activity against several Gram-positive and Gram-negative bacteria was then evaluated. The results of biological experiments showed that the synthetic compounds\n                    <jats:bold>5b<\/jats:bold>\n                    ,\n                    <jats:bold>5d<\/jats:bold>\n                    , and\n                    <jats:bold>5h<\/jats:bold>\n                    derivatives have moderate antimicrobial activity against\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    ,\n                    <jats:italic>Staphylococcus epidermidis<\/jats:italic>\n                    ,\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    ,\n                    <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                    , and\n                    <jats:italic>Candida albicans<\/jats:italic>\n                    compared to some standard drugs. Non-toxic compounds were selected based on MTT and hemolysis assays, and their synergistic effect in combination with levofloxacin (LEV) was investigated. The findings confirmed the effectiveness of combination therapy in reducing the dose of LEV, compounds\n                    <jats:bold>5d<\/jats:bold>\n                    and\n                    <jats:bold>5h<\/jats:bold>\n                    against S.\n                    <jats:italic>aureus<\/jats:italic>\n                    and\n                    <jats:italic>S. epidermidis<\/jats:italic>\n                    , as well as\n                    <jats:bold>5d<\/jats:bold>\n                    and\n                    <jats:bold>5b<\/jats:bold>\n                    against resistant isolates of MRSA and\n                    <jats:italic>P. aeruginosa<\/jats:italic>\n                    , respectively, with a fractional inhibitory concentration index\u2009\u2264\u20090.5. Field-emission scanning electron microscopy confirmed the complete damage of\n                    <jats:italic>S. aureus<\/jats:italic>\n                    ,\n                    <jats:italic>S. epidermidis<\/jats:italic>\n                    , and\n                    <jats:italic>P. aeruginosa<\/jats:italic>\n                    following exposure to the combination therapy of compounds\n                    <jats:bold>5b<\/jats:bold>\n                    ,\n                    <jats:bold>5d<\/jats:bold>\n                    , and\n                    <jats:bold>5h<\/jats:bold>\n                    with LEV. This new synergistic therapy has the potential to be used as a novel approach of treating infectious diseases after future investigations.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-39141-y","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T11:34:30Z","timestamp":1771500870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of antimicrobial activity of [1,2,4]triazolo[4, 3-a]quinoxaline derivatives individually and in combination with levofloxacin"],"prefix":"10.1038","volume":"16","author":[{"given":"Nasrin Saberi","family":"Harooni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Naimi-Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ghorban","family":"Dekamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azar","family":"Tahghighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"39141_CR1","doi-asserted-by":"publisher","first-page":"1517772","DOI":"10.3389\/fmicb.2025.1517772","volume":"16","author":"A Karnwal","year":"2025","unstructured":"Karnwal, A. et al. Addressing the global challenge of bacterial drug resistance: insights, strategies, and future directions. Front. Microbiol. 16, 1517772 (2025).","journal-title":"Front. Microbiol."},{"key":"39141_CR2","doi-asserted-by":"publisher","first-page":"31103","DOI":"10.1038\/s41598-025-11182-9","volume":"15","author":"R Bouzammit","year":"2025","unstructured":"Bouzammit, R. et al. Synthesis, crystal structure, DFT calculations, in-vitro and in-silico studies of novel chromone-isoxazoline conjugates as antibacterial and anti-inflammatory agents. Sci. Rep. 15, 31103 (2025).","journal-title":"Sci. Rep."},{"key":"39141_CR3","doi-asserted-by":"crossref","unstructured":"Provenzani, R. et al. Multisubstituted pyrimidines effectively inhibit bacterial growth and biofilm formation of Staphylococcus aureus. Sci. Rep. 11, 7931 (2021).","DOI":"10.1038\/s41598-021-86852-5"},{"key":"39141_CR4","doi-asserted-by":"publisher","first-page":"100606","DOI":"10.1016\/j.rechem.2022.100606","volume":"4","author":"E Kabir","year":"2022","unstructured":"Kabir, E. & Uzzaman, M. A review on biological and medicinal impact of heterocyclic compounds. Results Chem. 4, 100606 (2022).","journal-title":"Results Chem."},{"key":"39141_CR5","doi-asserted-by":"publisher","first-page":"7263","DOI":"10.1038\/s41598-018-25407-7","volume":"8","author":"PS Hameed","year":"2018","unstructured":"Hameed, P. S. et al. Nitrothiophene carboxamides, a novel narrow spectrum antibacterial series: mechanism of action and efficacy. Sci. Rep. 8, 7263 (2018).","journal-title":"Sci. Rep."},{"key":"39141_CR6","doi-asserted-by":"crossref","unstructured":"Hassan, S. A. & Abdullah, M. N. Synthesis of new imidazole derivatives bearing a morpholine moiety: molecular docking, DFT (FOMs, MEP, RDG, ELF, LOL) analysis, and evaluation of antimicrobial, anti-inflammatory (In Vivo\/In Vitro), toxicity, and hemolytic activities. J. Mol. Struct. 143286 (2025).","DOI":"10.1016\/j.molstruc.2025.143286"},{"key":"39141_CR7","doi-asserted-by":"crossref","unstructured":"Hassan, S. A. & Abdullah, M. N. Synthesis of new 4-thiazolidinone bearing thiazole, assess anticancer, and antimicrobial activities: insights from DFT, and molecular mocking. J. Mol. Struct. 143181 (2025).","DOI":"10.1016\/j.molstruc.2025.143181"},{"key":"39141_CR8","first-page":"489","volume":"5","author":"MAZ El-Attar","year":"2015","unstructured":"El-Attar, M. A. Z. et al. Design and synthesis of some new 1, 2, 4-triazolo (4, 3a) Quinoxaline derivatives as potential antimicrobialagents. Med. chem. 5, 489\u2013495 (2015).","journal-title":"Med. chem."},{"key":"39141_CR9","doi-asserted-by":"publisher","first-page":"712","DOI":"10.2174\/0929867327666200206114936","volume":"28","author":"C Patinote","year":"2021","unstructured":"Patinote, C., Cirnat, N., Bonnet, P. A. & Deleuze-Masqu\u00e9fa, C. Fused Azolo-Quinoxalines: candidates for medicinal Chemistry. A review of their biological applications. Curr. Med. Chem. 28, 712\u2013749 (2021).","journal-title":"Curr. Med. Chem."},{"key":"39141_CR10","doi-asserted-by":"publisher","first-page":"e202301401","DOI":"10.1002\/slct.202301401","volume":"8","author":"G Chawla","year":"2023","unstructured":"Chawla, G., Gupta, O. & Pradhan, T. A review on multipurpose potential of bioactive heterocycle Quinoxaline. ChemistrySelect 8, e202301401 (2023).","journal-title":"ChemistrySelect"},{"key":"39141_CR11","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ejmech.2017.11.064","volume":"143","author":"S Tariq","year":"2018","unstructured":"Tariq, S., Somakala, K., Amir, M. & Quinoxaline An insight into the recent Pharmacological advances. Eur. J. Med. Chem. 143, 542\u2013557 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"39141_CR12","doi-asserted-by":"publisher","first-page":"20881","DOI":"10.1038\/s41598-022-24030-x","volume":"12","author":"MA El-Naggar","year":"2022","unstructured":"El-Naggar, M. A. et al. One pot synthesis of two potent ag (I) complexes with Quinoxaline ligand, X-ray structure, Hirshfeld analysis, antimicrobial, and antitumor investigations. Sci. Rep. 12, 20881 (2022).","journal-title":"Sci. Rep."},{"key":"39141_CR13","doi-asserted-by":"publisher","first-page":"927","DOI":"10.2174\/1389557521666210927123831","volume":"22","author":"A Sharma","year":"2022","unstructured":"Sharma, A., Deep, A., Marwaha, M. G. & Marwaha, R. K. Quinoxaline: A chemical moiety with spectrum of interesting biological activities. Mini Rev. Med. Chem. 22, 927\u2013948 (2022).","journal-title":"Mini Rev. Med. Chem."},{"key":"39141_CR14","doi-asserted-by":"crossref","unstructured":"Waseem, A. M. et al. An insight into the therapeutic impact of quinoxaline derivatives: Recent advances in biological activities (2020\u20132024). Res. Chem. 101989 (2024).","DOI":"10.1016\/j.rechem.2024.101989"},{"key":"39141_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1134\/S1068162022040069","volume":"48","author":"V Bala Aakash","year":"2022","unstructured":"Bala Aakash, V., Ramalakshmi, N., Bhuvaneswari, S., Sankari, E. & Arunkumar, S. Comprehensive review on versatile pharmacology of quinoxaline derivative. Russ J. Bioorg. Chem. 48, 657\u2013677 (2022).","journal-title":"Russ J. Bioorg. Chem."},{"key":"39141_CR16","unstructured":"Mamedov, V. A. Quinoxalines: Synthesis, Reactions, Mechanisms and Structure. (Springer, 2016)."},{"key":"39141_CR17","unstructured":"Khudair, M. et al. Triazole, properties and its medical applications."},{"key":"39141_CR18","doi-asserted-by":"publisher","first-page":"864286","DOI":"10.3389\/fmolb.2022.864286","volume":"9","author":"MM Matin","year":"2022","unstructured":"Matin, M. M. et al. Triazoles and their derivatives: Chemistry, synthesis, and therapeutic applications. Front. Mol. Biosci. 9, 864286 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"39141_CR19","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1080\/10406638.2021.1878246","volume":"42","author":"CKR Reddivari","year":"2022","unstructured":"Reddivari, C. K. R. et al. Design, synthesis, biological evaluation and molecular Docking studies of 1, 4-disubstituted 1, 2, 3-triazoles: PEG-400: H2O mediated click reaction of fluorescent organic probes under ultrasonic irradiation. Polycycl. Aromat. Compd. 42, 3953\u20133974 (2022).","journal-title":"Polycycl. Aromat. Compd."},{"key":"39141_CR20","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1021\/acs.jmedchem.4c00652","volume":"67","author":"Q Guan","year":"2024","unstructured":"Guan, Q. et al. Triazoles in medicinal chemistry: physicochemical properties, bioisosterism, and application. J. Med. Chem. 67, 7788\u20137824 (2024).","journal-title":"J. Med. Chem."},{"key":"39141_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s43094-021-00241-3","volume":"7","author":"S Kumar","year":"2021","unstructured":"Kumar, S., Khokra, S. L. & Yadav, A. Triazole analogues as potential Pharmacological agents: A brief review. Fut. J. Pharm. Sci. 7, 106 (2021).","journal-title":"Futur J. Pharm. Sci."},{"key":"39141_CR22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41589-019-0404-5","volume":"16","author":"HS Hahm","year":"2020","unstructured":"Hahm, H. S. et al. Global targeting of functional tyrosines using sulfur-triazole exchange chemistry. Nat. Chem. Biol. 16, 150\u2013159 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"39141_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s41348-020-00372-4","volume":"128","author":"LN J\u00f8rgensen","year":"2021","unstructured":"J\u00f8rgensen, L. N. et al. Decreasing Azole sensitivity of Z. tritici in Europe contributes to reduced and varying field efficacy. J. Plant. Dis. Prot. 128, 287\u2013301 (2021).","journal-title":"J. Plant. Dis. Prot."},{"key":"39141_CR24","doi-asserted-by":"publisher","first-page":"115603","DOI":"10.1016\/j.ejmech.2023.115603","volume":"259","author":"G Tian","year":"2023","unstructured":"Tian, G. et al. Recent advances in 1, 2, 3-and 1, 2, 4-triazole hybrids as antimicrobials and their SAR: A critical review. Eur. J. Med. Chem. 259, 115603 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"39141_CR25","doi-asserted-by":"publisher","first-page":"19805","DOI":"10.3390\/molecules201119655","volume":"20","author":"AR Al-Marhabi","year":"2015","unstructured":"Al-Marhabi, A. R., Abbas, H. A. S. & Ammar, Y. A. Synthesis, characterization and biological evaluation of some Quinoxaline derivatives: A promising and potent new class of antitumor and antimicrobial agents. Molecules 20, 19805\u201319822 (2015).","journal-title":"Molecules"},{"key":"39141_CR26","doi-asserted-by":"publisher","first-page":"25395","DOI":"10.1021\/acsomega.4c03906","volume":"9","author":"M El Faydy","year":"2024","unstructured":"El Faydy, M. et al. Synthesis, biological properties, and molecular Docking study of novel 1, 2, 3-triazole-8-quinolinol hybrids. ACS Omega. 9, 25395\u201325409 (2024).","journal-title":"ACS Omega"},{"key":"39141_CR27","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.4155\/fmc-2018-0082","volume":"10","author":"Z El-Attar","year":"2018","unstructured":"El-Attar, Z., Elbayaa, M. A. & Shaaban, R. Y. Synthesis of pyrazolo-1, 2, 4-triazolo [4, 3-a] quinoxalines as antimicrobial agents with potential Inhibition of DHPS enzyme. Future Med. Chem. 10, 2155\u20132175 (2018).","journal-title":"Future Med. Chem."},{"key":"39141_CR28","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.3390\/biomedicines10092219","volume":"10","author":"N Basavegowda","year":"2022","unstructured":"Basavegowda, N. & Baek, K. H. Combination strategies of different antimicrobials: an efficient and alternative tool for pathogen inactivation. Biomedicines 10, 2219 (2022).","journal-title":"Biomedicines"},{"key":"39141_CR29","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.7150\/thno.56205","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria. Theranostics 11, 4910 (2021).","journal-title":"Theranostics"},{"key":"39141_CR30","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1080\/17568919.2024.2423596","volume":"16","author":"MU Rehman","year":"2024","unstructured":"Rehman, M. U. & Long, S. Progress and challenges in the development of Triazole antimicrobials. Future Med. Chem. 16, 2451\u20132453 (2024).","journal-title":"Future Med. Chem."},{"key":"39141_CR31","doi-asserted-by":"publisher","first-page":"e14555","DOI":"10.1111\/cbdd.14555","volume":"103","author":"A Tahghighi","year":"2024","unstructured":"Tahghighi, A. & Azerang, P. Click chemistry beyond metal-catalyzed cycloaddition as a remarkable tool for green chemical synthesis of antifungal medications. Chem. Biol. Drug Des. 103, e14555 (2024).","journal-title":"Chem. Biol. Drug Des."},{"key":"39141_CR32","doi-asserted-by":"publisher","first-page":"16663","DOI":"10.1038\/s41598-025-01075-2","volume":"15","author":"D Kubera","year":"2025","unstructured":"Kubera, D. et al. Synergistic effect of synthetic derivatives of 1, 3, 4-thiadiazole with amphotericin B in antifungal therapy. Sci. Rep. 15, 16663 (2025).","journal-title":"Sci. Rep."},{"key":"39141_CR33","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41598-020-80227-y","volume":"11","author":"MI Islam","year":"2021","unstructured":"Islam, M. I. et al. Antimicrobial activity of IDD-B40 against drug-resistant Mycobacterium tuberculosis. Sci. Rep. 11, 740 (2021).","journal-title":"Sci. Rep."},{"key":"39141_CR34","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez, A. et al. Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA. Sci. Rep. 911294 (2019).","DOI":"10.1038\/s41598-019-47746-9"},{"issue":"3","key":"39141_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jphs.2018.07.005","volume":"137","author":"Z Fang","year":"2018","unstructured":"Fang, Z. et al. A quinoline-based FtsZ inhibitor for the study of antimicrobial activity and synergistic effects with \u03b2-lactam antibiotics. J. Pharmacol. Sci. 137 (3), 283\u2013289 (2018).","journal-title":"J. Pharmacol. Sci."},{"key":"39141_CR36","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1128\/AAC.01418-09","volume":"54","author":"SA Rogers","year":"2010","unstructured":"Rogers, S. A., Huigens, R. W. III, Cavanagh, J. & Melander, C. Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents. Antimicrob. Agents Chemother. 54, 2112\u20132118 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"39141_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.compbiolchem.2018.05.021","volume":"76","author":"R Srivastava","year":"2018","unstructured":"Srivastava, R. et al. Synthesis, antibacterial activity, synergistic effect, cytotoxicity, Docking and molecular dynamics of benzimidazole analogues. Comput. Biol. Chem. 76, 1\u201316 (2018).","journal-title":"Comput. Biol. Chem."},{"key":"39141_CR38","doi-asserted-by":"publisher","first-page":"104255","DOI":"10.1016\/j.bioorg.2020.104255","volume":"104","author":"EM Abbass","year":"2020","unstructured":"Abbass, E. M., Khalil, A. K., Mohamed, M. M., Eissa, I. H. & El-Naggar, A. M. Design, efficient synthesis, Docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers. Bioorg. Chem. 104, 104255 (2020).","journal-title":"Bioorg. Chem."},{"key":"39141_CR39","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/j.tetlet.2016.03.110","volume":"57","author":"SC Mwakwari","year":"2016","unstructured":"Mwakwari, S. C., Bess, L. S., Bazin, H. G. & Johnson, D. A. Efficient tin-mediated synthesis of lysophospholipid conjugates of a TLR7\/8-active imidazoquinoline. Tetrahedron Lett. 57, 2093\u20132096 (2016).","journal-title":"Tetrahedron Lett."},{"key":"39141_CR40","doi-asserted-by":"publisher","first-page":"137041","DOI":"10.1016\/j.molstruc.2023.137041","volume":"1298","author":"MMS Al Ward","year":"2024","unstructured":"Al Ward, M. M. S., Abdallah, A. E., Zayed, M. F., Ayyad, R. R. & El-Zahabi, M. A. Design, synthesis and biological evaluation of newly triazolo-quinoxaline based potential Immunomodulatory anticancer molecules. J. Mol. Struct. 1298, 137041 (2024).","journal-title":"J. Mol. Struct."},{"issue":"13","key":"39141_CR41","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1016\/j.bmc.2019.05.006","volume":"27","author":"X Bi","year":"2019","unstructured":"Bi, X. et al. Design, synthesis and biological evaluation of novel 4, 5-dihydro-[1, 2, 4] Triazolo [4, 3-f] pteridine derivatives as potential BRD4 inhibitors. Bioorg. Med. Chem. 27 (13), 2813\u20132821 (2019).","journal-title":"Bioorg. Med. Chem."},{"key":"39141_CR42","doi-asserted-by":"publisher","first-page":"e1234","DOI":"10.1097\/IPC.0000000000001234","volume":"31","author":"LM Bush","year":"2023","unstructured":"Bush, L. M. & Williams, J. Leuconostoc lactis bacteremia and neutropenic fever: an infrequently encountered Vancomycin-Resistant Gram-Positive cocci: A case report and review. Infect. Dis. Clin. Pract. 31, e1234 (2023).","journal-title":"Infect. Dis. Clin. Pract."},{"key":"#cr-split#-39141_CR43.1","doi-asserted-by":"crossref","unstructured":"Burke, \u00d3., Zeden, M. S. & O'Gara, J. P. The pathogenicity and virulence of the opportunistic pathogen Staphylococcus epidermidis. Burke, \u00d3rla, Merve S Zeden, James P O'Gara 2024 The Pathog Virulence Opportunistic Pathog Staphylococcus Epidermidis Virulence 15","DOI":"10.1080\/21505594.2024.2359483"},{"key":"#cr-split#-39141_CR43.2","unstructured":"(1) 2359483Virulence. 15, 2359483 (2024)."},{"key":"39141_CR44","unstructured":"Letizia, M., Diggle, S. P. & Whiteley, M. Pseudomonas aeruginosa: ecology, evolution, pathogenesis and antimicrobial susceptibility. Nat Rev. Microbiol. 1\u201317 (2024)."},{"key":"39141_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/jof7020079","volume":"7","author":"J Talapko","year":"2021","unstructured":"Talapko, J. et al. Candida albicans\u2014the virulence factors and clinical manifestations of infection. J. Fungi. 7, 79 (2021).","journal-title":"J. Fungi"},{"key":"39141_CR46","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1007\/s00044-011-9753-7","volume":"21","author":"MA Henen","year":"2012","unstructured":"Henen, M. A., El Bialy, S. A. A., Goda, F. E., Nasr, M. N. A. & Eisa, H. M. [1,2,4]Triazolo[4,3-a]quinoxaline: Synthesis, antiviral, and antimicrobial activities. Med. Chem. Res. 21, 2368\u20132378 (2012).","journal-title":"Med. Chem. Res."},{"key":"39141_CR47","unstructured":"Ayoup, M. S. et al. Synthesis, Docking, and evaluation of. J. Heterocycl. Chem. 53 (2016)."},{"key":"39141_CR48","doi-asserted-by":"crossref","unstructured":"Tambe, V., Ditani, A., Rajpoot, K. & Tekade, R. K. Pharmacokinetics aspects of structural modifications in drug design and therapy. In: Biopharmaceutics and Pharmacokinetics Considerations. 83\u2013108 (Elsevier, 2021).","DOI":"10.1016\/B978-0-12-814425-1.00014-0"},{"key":"39141_CR49","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2174\/1381612826666200206093815","volume":"26","author":"M Fesatidou","year":"2020","unstructured":"Fesatidou, M., Petrou, A. & Athina, G. Heterocycle compounds with antimicrobial activity. Curr. Pharm. Des. 26, 867\u2013904 (2020).","journal-title":"Curr. Pharm. Des."},{"key":"39141_CR50","doi-asserted-by":"publisher","first-page":"137282","DOI":"10.1016\/j.molstruc.2023.137282","volume":"1301","author":"SA Hassan","year":"2024","unstructured":"Hassan, S. A., Ziwar, J. B., muhammed Aziz, D. & Abdullah, M. N. Sonochemical synthesis of new Thiazolidin-4-one derivatives as potent anticancer and antimicrobial agents with Docking design, and energy gap Estimation. J. Mol. Struct. 1301, 137282 (2024).","journal-title":"J. Mol. Struct."},{"key":"39141_CR51","doi-asserted-by":"publisher","first-page":"141923","DOI":"10.1016\/j.molstruc.2025.141923","volume":"1335","author":"M Ghods","year":"2025","unstructured":"Ghods, M., Almasirad, A. & Tahghighi, A. Synthesis and in vitro anti-bacterial activity of novel quinoline-based aryl\/heteroaryl amide hybrids. J. Mol. Struct. 1335, 141923 (2025).","journal-title":"J. Mol. Struct."},{"key":"39141_CR52","doi-asserted-by":"publisher","first-page":"15493","DOI":"10.3390\/ijms242015493","volume":"24","author":"G Xiao","year":"2023","unstructured":"Xiao, G., Li, J. & Sun, Z. The combination of antibiotic and non-antibiotic compounds improves antibiotic efficacy against multidrug-resistant bacteria. Int. J. Mol. Sci. 24, 15493 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"39141_CR53","doi-asserted-by":"publisher","first-page":"1556335","DOI":"10.3389\/fphar.2025.1556335","volume":"16","author":"M Pahlevani","year":"2025","unstructured":"Pahlevani, M. et al. Antibacterial and wound healing effects of PEG-coated ciprofloxacin-loaded ZIF-8 nanozymes against ciprofloxacin-resistant Pseudomonas aeruginosa taken from burn wounds. Front. Pharmacol. 16, 1556335 (2025).","journal-title":"Front. Pharmacol."},{"key":"39141_CR54","doi-asserted-by":"publisher","first-page":"35001","DOI":"10.1088\/1748-605X\/abc7f2","volume":"16","author":"M Zafari","year":"2021","unstructured":"Zafari, M. et al. Effects of cefazolin-containing niosome nanoparticles against methicillin-resistant Staphylococcus aureus biofilm formed on chronic wounds. Biomed. Mater. 16, 35001 (2021).","journal-title":"Biomed. Mater."},{"key":"39141_CR55","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/lam.13692","volume":"75","author":"M Nabizadeh","year":"2022","unstructured":"Nabizadeh, M., Naimi-Jamal, M. R., Rohani, M., Azerang, P. & Tahghighi, A. Hydrazone analogues with promising antibacterial profiles: Synthesis, morphology, in vitro and in Silico approaches. Lett. Appl. Microbiol. 75, 667\u2013679 (2022).","journal-title":"Lett. Appl. Microbiol."},{"key":"39141_CR56","unstructured":"Clinical and Laboratory Standards Institute (Ed.). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: M07\u2013A10; Approved Standard 10th edn (Clinical Laboratory Standards, 2015)."},{"key":"39141_CR57","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1021\/acsinfecdis.9b00049","volume":"5","author":"R Namivandi-Zangeneh","year":"2019","unstructured":"Namivandi-Zangeneh, R. et al. Synergy between synthetic antimicrobial polymer and antibiotics: a promising platform to combat multidrug-resistant bacteria. ACS Infect. Dis. 5, 1357\u20131365 (2019).","journal-title":"ACS Infect. Dis."},{"key":"39141_CR58","doi-asserted-by":"crossref","unstructured":"Saberi Harooni, N. et al. Antibacterial efficacy of pyranopyrimidinone derivatives synthesized using a facile one-pot reaction. Res. Chem. Intermed..1\u201318 (2024).","DOI":"10.1007\/s11164-024-05337-y"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39141-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39141-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39141-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:29:48Z","timestamp":1781634588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39141-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39141"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39141-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9902"}}